BERTOLINI, STEFANO
 Distribuzione geografica
Continente #
EU - Europa 15.711
AS - Asia 1.363
NA - Nord America 428
SA - Sud America 107
AF - Africa 28
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 17.639
Nazione #
IT - Italia 15.485
SG - Singapore 624
US - Stati Uniti d'America 403
CN - Cina 375
VN - Vietnam 213
FR - Francia 127
BR - Brasile 68
HK - Hong Kong 44
FI - Finlandia 23
AR - Argentina 21
MX - Messico 18
JP - Giappone 16
CH - Svizzera 14
DE - Germania 14
IQ - Iraq 14
IN - India 13
BD - Bangladesh 8
GB - Regno Unito 8
ID - Indonesia 7
SA - Arabia Saudita 7
NL - Olanda 6
RU - Federazione Russa 6
TH - Thailandia 6
ZA - Sudafrica 6
UA - Ucraina 5
CL - Cile 4
IE - Irlanda 4
PE - Perù 4
PH - Filippine 4
TR - Turchia 4
VE - Venezuela 4
DZ - Algeria 3
ES - Italia 3
KR - Corea 3
PK - Pakistan 3
PL - Polonia 3
PS - Palestinian Territory 3
TN - Tunisia 3
TW - Taiwan 3
AT - Austria 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CA - Canada 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
EG - Egitto 2
JM - Giamaica 2
KE - Kenya 2
MA - Marocco 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BJ - Benin 1
BY - Bielorussia 1
CM - Camerun 1
CO - Colombia 1
CY - Cipro 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MG - Madagascar 1
ML - Mali 1
MN - Mongolia 1
MY - Malesia 1
NA - Namibia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
PR - Porto Rico 1
PY - Paraguay 1
SE - Svezia 1
SN - Senegal 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 17.639
Città #
Genova 10.644
Genoa 2.813
Rapallo 1.131
Vado Ligure 860
Singapore 275
San Jose 183
Lauterbourg 122
Ashburn 71
Hanoi 58
Ho Chi Minh City 54
Beijing 38
Hong Kong 38
New York 38
Santa Clara 24
Helsinki 23
Tokyo 15
Council Bluffs 14
Zurich 14
Frankfurt am Main 12
Bordighera 11
Mexico City 11
Haiphong 9
Tianjin 8
Los Angeles 6
City of London 5
Da Nang 5
Orem 5
Amsterdam 4
Des Moines 4
Dublin 4
New Delhi 4
Quảng Ngãi 4
Riyadh 4
Boardman 3
Can Tho 3
Ha Long 3
Hangzhou 3
Hải Dương 3
Johannesburg 3
Monte Grande 3
Moscow 3
Nha Trang 3
Rio de Janeiro 3
Shanghai 3
Thái Bình 3
Ankara 2
Antakya 2
Baghdad 2
Baku 2
Bangkok 2
Buffalo 2
Campinas 2
Caracas 2
Casablanca 2
Chicago 2
Doha 2
Durban 2
Guadalajara 2
Ludhiana 2
Montevideo 2
Mosul 2
Nanjing 2
Ninh Bình 2
Nuremberg 2
Phú Thọ 2
Quilmes 2
Rome 2
Santiago 2
Sassari 2
Shenzhen 2
Sorocaba 2
Sumaré 2
São Paulo 2
Ấp Tháp Mười 2
Abu Dhabi 1
Addis Ababa 1
Alexandria 1
Alvorada 1
Americana 1
Amman 1
Antananarivo 1
Anyang 1
Araguaiana 1
Aryanah 1
Asunción 1
Athens 1
Atlanta 1
Avellaneda 1
Bamako 1
Bandung 1
Bari 1
Barika 1
Basra 1
Bedford 1
Belo Horizonte 1
Betim 1
Binangonan 1
Biên Hòa 1
Bofete 1
Bologna 1
Totale 16.631
Nome #
Lipoproteins, stroke and statins. 216
A complex phenotype in a child with familial HDL deficiency due to a novel frameshift mutation in APOA1 gene (apoA-IGuastalla) 203
Baseline hs-CRP predicts hypertension remission in metabolic syndrome 194
Spectrum of mutations of the LPL gene identified in Italy in patients with severe hypertriglyceridemia 191
Additive effect of mutations in LDLR and PCSK9 genes on the phenotype of familial hypercholesterolemia 184
Effect of ezetimibe coadministered with statins in genotype-confirmed heterozygous FH patients. 183
A silent mutation of Niemann-Pick C1-like 1 and apolipoprotein E4 modulate cholesterol absorption in primary hyperlipidemias. 179
A three month-old infant with severe hyperchylomicronemia: molecular diagnosis and extracorporeal treatment. 179
A “de novo” mutation of the LDL-receptor gene as the cause of familial hypercholesterolemia. 174
A study of fatty liver disease and plasma lipoproteins in a kindred with Familial Hypobeta-lipoproteinemia due to a novel truncated form of apolipoprotein B (Apo B 54.5). 169
Cholesteryl Ester Storage Disease (CESD) due to novel mutations in the LIPA gene. 169
A point mutation in ABC1 gene in a patient with severe premature coronary heart disease and mild clinical phenotype of Tangier disease 168
A Third Major Locus for Autosomal Dominant Hypercholesterolemia maps at 1p34.1-p32. 166
A novel mutation of the apolipoprotein A-I gene in a family with familial combined hyperlipidemia 164
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study). 164
Genetic polymorphisms affecting the phenotypic expression in familial hypercholesterolemia 163
An apparent inconsistency in parent to offspring transmission of point mutations of LDLR gene in familial hypercholesterolemia. 162
Autosomal recessive hypercholesterolemia (ARH) and homozygous familial hypercholesterolemia (FH): a phenotypic comparison. 162
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 159
Lysosomal lipase deficiency: Molecular characterization of eleven patients with Wolman or cholesteryl ester storage disease. 158
Abnormal splicing of ABCA1 pre-mRNA in Tangier disease due to a IVS2 +5G>C mutation in ABCA1 gene 157
Mutations in MTP gene in abeta- and hypobeta-lipoproteinemia. 156
A novel sequence variant in APOA5 gene found in patients with severe hypertriglyceridemia. 156
HEMORHEOLOGICAL AND CEREBRAL BLOOD FLOW CHANGES INDUCED BY LDL- APHERESIS IN FAMILIAL HYPERCHOLESTEROLEMIC PATIENTS. 155
A new missense mutation (Cys297-->Phe) of the low density lipoprotein receptor in Italian patients with familial hypercholesterolemia (FHTrieste). 154
Timely diagnosis of sitosterolemia by next generation sequencing in two children with severe hypercholesterolemia 154
Familial HDL deficiency due to ABCA1 gene mutations with or without other genetic lipoprotein disorders. 153
Multiple abnormally spliced ABCA1 mRNAs caused by a novel splice site mutation of ABCA1 gene in a patient with Tangier disease. 153
A ‘de novo’ point mutation of the low-density lipoprotein receptor gene in an Italian subject with primary hypercholesterolemia 152
A 33-year-old man with nephrotic syndrome and lecithin-cholesterol acyltransferase (LCAT) deficiency. Description of two new mutations in the LCAT gene 151
Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy. 151
Four novel partial deletions of LDL receptor gene in Italian patients with Familial Hypercholesterolemia 150
Use of three DNA polymorphisms of the LDL-receptor gene in the diagnosis of Familial Hypercholesterolemia. 149
Regional cerebral blood flow in familial hypercholesterolemia 149
Long term substrate reduction therapy with ezetimibe alone or associated with statins in three adult patients with lysosomal acid lipase deficiency 149
Analysis of LDL receptor gene mutations in Italian patients with homozygous Familial Hypercholesterolemia 148
Duplication of exons 13, 14 and 15 of LDL-receptor gene in a patient with heterozygous Familial Hypercholesterolemia. 147
Heterozygosity for lysosomal acid lipase E8SJM mutation and serum lipid concentrations. 147
Pseudodominance of lipoprotein lipase (LPL) deficiency due to a nonsense mutation (Tyr302>Term) in exon 6 of LPL gene in an Italian family from Sardinia (LPL Olbia). 145
Identification of an alternative transcript of ABCA1 gene in different human cell types. 144
Severe HDL deficiency due to novel defects in the ABCA1 transporter. 143
The type of LDLR gene mutation predicts cardiovascular risk in children with familial hypercholesterolemia 143
Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e. 142
Quantitative polymerase chain reaction and microchip electrophoresis to detect major rearrangements of the low-density lipoprotein receptor gene causing familial hypercholesterolemia. 142
Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency. 142
Chorionic DNA analysis for the prenatal diagnosis of familial hypercholesterolemia. 141
Correlation between Progetto Cuore risk score and early cardiovascular damage in never treated subjects 141
Presence of soluble amyloid beta peptide precedes amyloid plaque formation in Down's syndrome 139
Altered mRNA splicing in lipoprotein disorders. 139
Serum homocysteine, methylenetetrahydrofolate reductase gene polymorphism and cardiovascular disease in heterozygous familial hypercholesterolemia. 139
Serum lipoprotein (a) predicts acute coronary syndromes in patients with severe carotid stenosis 139
Physical activity modulates effects of some genetic polymorphisms affecting cardiovascular risk in men aged over 40 years. 136
Two Italian Kindreds Carrying the Arg136>Ser Mutation of Apo E Gene: Development of Premature and Severe Atherosclerosis in the presence of Epsilon 2 as Second Allele 135
Pseudoxanthoma elasticum and familial hypercholesterolemia: A deleterious combination of cardiovascular risk factors 135
Cerebrotendinous xanthomatosis caused by two new mutations of sterol-27-hydroxylase gene that disrupt mRNA splicing. 135
Homozygous familial hypercholesterolemia in Italy: Clinical and molecular features 135
Blood and synovial levels of piroxicam and their effects on some metabolites of arachidonic acid 134
Pvu II polymorphism of low density lipoprotein receptor gene and familial hypercholesterolemia. Study of Italians. 134
Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs) 134
Leucine 10 allelic variant in signal peptide of PCSK9 increases the LDL cholesterol-lowering effect of statins in patients with familial hypercholesterolaemia. 133
Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins: a study in centenarians. 132
p53 variants predisposing to cancer are present in healthy centenarians. 132
Recurrent mutations of the apolipoprotein A-I gene in three kindreds with severe HDL deficiency. 131
Mechanisms and genetic determinants regulating sterol absorption, circulating LDL levels and sterol elimination: implications for classification and disease risk 130
Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes 129
LDL apheresis in a homozygous familial hypercholesterolemic child aged 4.5. 129
Paradoxes in longevity: sequence analysis of mtDNA haplogroup J in centenarians. 128
Polymorphisms of Drug-Metabolizing Enzymes in healthy Nonagenarians and Centenarians: difference at GSTT1 locus. 128
Autosomal recessive hypercholesterolemia caused by mutations in a putative LDL Receptor Adaptor Protein. 127
Italian familial defective apolipoprotein B patients share a unique haplotype with other Caucasian patients. 126
Hypocomplementemic type II membranoproliferative glomerulonephritis in a male patient with familial lecithin-cholesterol acyltransferase deficiency due to two different allelic mutations. 126
A large deletion in the LDL-receptor gene. The cause of Familial Hypercholesterolemia in three italian families: a study that dates back to the 17th century (FH Pavia). 125
Effects of a phytosterol-enriched dairy product on lipids, sterols and 8-isoprostane in hypercholesterolemic patients: a multicenter Italian study. 125
Partial duplication of the EGF precursor homology domain of the LDL-receptor protein causing Familial Hypercholesterolemia (FH Salerno) 125
Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia. 124
Alternative splicing of mutant LDL-receptor mRNA in an Italian patient with familial hypercholesterolemia due to a partial deletion of LDL-receptor gene (FH Potenza). 124
Analysis of two duplications of the LDL receptor gene affecting intracellular transport, catabolism, and surface binding of the LDL receptor. 124
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysis. 124
Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia. 123
Molecular characterization of two patients with severe LCAT deficiency. 122
Mitochondrial DNA inherited variants are associated with successful aging and longevity in humans. 121
Functional analysis of the promoter of human sterol 27-hydroxylase gene in HepG2 cells. 120
Effects of three low-dose oral contraceptive formulations on lipid metabolism. 120
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinemia. 119
Characterization of three mutations of LDL-receptor gene in Italians patients with Familial Hypercholesterolemia. 119
Mutant factor V (Arg506Gln) in healthy centenarians. 117
Occurrence of multiple aberrantly spliced mRNAs of LDL-receptor Gene upon a donor splice site mutation that causes Familial Hypercholesterolemia (FH-Benevento). 117
Hypobetalipoproteinemia with an apparently recessive inheritance due to a “de novo” mutation of apolipoprotein B. 116
DNA multiallelic systems reveal gene/longevity associations not detected by diallelic systems. The APOB locus. 116
Influence of beta(0)-thalassemia on the phenotypic expression of heterozygous familial hypercholesterolemia : a study of patients with familial hypercholesterolemia from Sardinia. 114
Efficacy and safety of atorvastatin compared to pravastatin in patients with hypercholesterolemia. 114
Gene/longevity association studies at four autosomal loci (REN, THO, PARP, SOD2). 114
Severe hypertriglyceridemia in a newborn with monogenic lipoprotein lipase deficiency: an unconventional therapeutic approach with exchange transfusion. 114
Low-density lipoprotein apheresis in a patient aged 3.5 years. 114
Four novel mutations of sterol-27-hydroxylase gene in Italian patients with cerebrotendinous xanthomatosis. 113
Pharmacological treatment of a Sardinian patient affected by autosomal recessive hypercholesterolemia (ARH) 113
Denaturing high-performance liquid chromatography (DHPLC) in the detection of mutations of ABCA1 gene in Familial HDL Deficiency. 112
Beta-sitosterolaemia: a new nonsense mutation in the ABCG5 gene. 112
Adaptor protein ARH is recruited to the plasma membrane by LDL binding and modulates endocytosis of the LDL/LDLR complex in hepatocytes. 111
Two novel partial deletions of LDL-receptor gene in Italian patients with familial hypercholesterolemia (FH Siracusa and FH Reggio Emilia). 111
Totale 14.129
Categoria #
all - tutte 49.371
article - articoli 49.371
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.742


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021259 0 0 0 0 0 0 0 0 0 101 85 73
2021/20221.599 54 126 105 222 34 136 117 367 65 135 63 175
2022/20231.385 148 62 30 124 264 300 3 103 241 5 92 13
2023/2024643 30 103 12 84 85 135 22 20 29 5 40 78
2024/20251.900 36 165 73 137 305 197 139 278 46 87 167 270
2025/20263.090 402 109 194 276 482 388 576 166 241 256 0 0
Totale 17.770